Search Legislation

Commission Implementing Decision of 30 November 2011 approving annual and multiannual programmes and the financial contribution from the Union for the eradication, control and monitoring of certain animal diseases and zoonoses presented by the Member States for 2012 and following years (notified under document C(2011) 8719) (2011/807/EU)

 Help about what version

What Version

 Help about advanced features

Advanced Features

More Resources

 Help about UK-EU Regulation

Legislation originating from the EU

When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.

Close

This item of legislation originated from the EU

Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).

Changes to legislation:

This version of this Decision was derived from EUR-Lex on IP completion day (31 December 2020 11:00 p.m.). It has not been amended by the UK since then. Find out more about legislation originating from the EU as published on legislation.gov.uk. Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.

CHAPTER IU.K. ANNUAL PROGRAMMES

Article 1U.K.Bovine brucellosis

1.The programmes for the eradication of bovine brucellosis submitted by Spain, Italy Portugal and the United Kingdom are hereby approved for the period from 1 January 2012 to 31 December 2012.

2.The financial contribution by the Union:

(a)shall consist of a lump sum compensating for all costs incurred to perform the following activities and/or tests:

(i)

EUR 0,5 per domestic animal sampled;

(ii)

EUR 0,2 per rose bengal test;

(iii)

EUR 0,2 per SAT test;

(iv)

EUR 0,4 per complement fixation test;

(v)

EUR 0,5 per ELISA test;

(vi)

EUR 10 per bacteriological test;

(vii)

EUR 1 per domestic animal vaccinated;

(b)shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of the compensation to be paid to owners for the value of their animals slaughtered subject to those programmes and shall on average not exceed EUR 375 per animal slaughtered; and

[F1(c) shall not exceed the following:

(i)

EUR 3 600 000 for Spain;

(ii)

EUR 2 300 000 for Italy;

(iii)

EUR 1 050 000 for Portugal;

(iv)

EUR 1 050 000 for the United Kingdom.]

Article 2U.K.Bovine tuberculosis

1.The programmes for the eradication of bovine tuberculosis submitted by Ireland, Spain, Italy Portugal and the United Kingdom are hereby approved for the period from 1 January 2012 to 31 December 2012.

2.The financial contribution by the Union:

[F1(a) shall consist of a lump sum compensating for all costs incurred to perform the following activities and/or tests:

(i)

EUR 0,5 per domestic animal sampled for gamma interferon test and suspected positive in the slaughterhouse;

(ii)

EUR 1,5 per tuberculin test;

(iii)

EUR 5 per gamma interferon test;

(iv)

EUR 20 per bacteriological test.]

(b)shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the compensation to be paid to owners for the value of their animals slaughtered subject to those programmes shall on average not exceed EUR 375 per animal slaughtered; and

[F1(c) shall not exceed the following:

(i)

EUR 19 000 000 for Ireland;

(ii)

EUR 14 000 000 for Spain;

(iii)

EUR 4 000 000 for Italy;

(iv)

EUR 2 650 000 for Portugal;

(v)

EUR 31 000 000 for the United Kingdom.]

Article 3U.K.Ovine and caprine brucellosis

1.The programmes for the eradication of ovine and caprine brucellosis submitted by Greece, Italy, Spain, Cyprus, and Portugal are hereby approved for the period from 1 January 2012 to 31 December 2012.

2.The financial contribution by the Union:

(a)shall consist of a lump sum compensating for all costs incurred to perform the following activities and/or tests:

(i)

EUR 0,5 per domestic animal sampled;

(ii)

EUR 0,2 per rose bengal test;

(iii)

EUR 0,4 per complement fixation test;

(iv)

EUR 10 per bacteriological test;

(v)

EUR 1 per domestic animal vaccinated;

(b)shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of the compensation to be paid to owners for the value of their animals slaughtered subject to those programmes and shall on average not exceed EUR 50 per animal slaughtered; and

[F1(c) shall not exceed the following:

(i)

EUR 800 000 for Greece;

(ii)

EUR 8 900 000 for Spain;

(iii)

EUR 3 700 000 for Italy;

(iv)

EUR 180 000 for Cyprus;

(v)

EUR 1 800 000 for Portugal.]

Article 4U.K.Bluetongue in endemic or high risk areas

1.The programmes for the eradication and monitoring of bluetongue submitted by Belgium, Bulgaria, the Czech Republic, Germany, Estonia, Ireland, Greece, Spain, France, Italy, Latvia, Lithuania, Luxembourg, Hungary, Malta, the Netherlands, Austria, Poland, Portugal, Romania, Slovenia, Slovakia, Finland and Sweden are hereby approved for the period from 1 January 2012 to 31 December 2012.

2.The financial contribution by the Union:

(a)shall consist of a lump sum compensating for all costs incurred to perform the following activities and/or tests:

(i)

EUR 0,5 per domestic animal sampled;

(ii)

EUR 1 per domestic animal vaccinated;

(iii)

EUR 2 per ELISA test;

(iv)

EUR 10 per PCR test;

(v)

EUR 10 per virological test;

(b)shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for:

(i)

the cost of carrying out laboratory tests for entomological surveillance;

(ii)

the purchase of traps; and

[F1(c) shall not exceed the following:

(i)

EUR 150 000 for Belgium;

(ii)

EUR 15 000 for Bulgaria;

(iii)

EUR 40 000 for the Czech Republic;

(iv)

EUR 80 000 for Germany;

(v)

EUR 10 000 for Estonia;

(vi)

EUR 25 000 for Ireland;

(vii)

EUR 60 000 for Greece;

(viii)

EUR 700 000 for Spain;

(ix)

EUR 1 200 000 for France;

(x)

EUR 650 000 for Italy;

(xi)

EUR 20 000 for Latvia;

(xii)

EUR 10 000 for Lithuania;

(xiii)

EUR 10 000 for Luxembourg;

(xiv)

EUR 30 000 for Hungary;

(xv)

EUR 10 000 for Malta;

(xvi)

EUR 20 000 for the Netherlands;

(xvii)

EUR 10 000 for Austria;

(xviii)

EUR 50 000 for Poland;

(xix)

EUR 300 000 for Portugal;

(xx)

EUR 150 000 for Romania;

(xxi)

EUR 40 000 for Slovenia;

(xxii)

EUR 50 000 for Slovakia;

(xxiii)

EUR 10 000 for Finland;

(xxiv)

EUR 10 000 for Sweden.]

Article 5U.K.Salmonellosis (zoonotic salmonella) in breeding, laying and broiler flocks of Gallus gallus and in flocks of turkeys (Meleagris gallopavo)

1.The programmes for the control of certain zoonotic salmonella in breeding, laying and broiler flocks of Gallus gallus and in flocks of turkeys (Meleagris gallopavo) submitted by Belgium, Bulgaria, the Czech Republic, Denmark, Germany, Estonia, Ireland, Greece, Spain, France, Italy, Cyprus, Latvia, Luxembourg, Hungary, Malta, the Netherlands, Austria, Portugal, Romania, Slovenia Slovakia, and the United Kingdom are hereby approved for the period from 1 January 2012 to 31 December 2012.

2.The programmes for the control of certain zoonotic salmonella in broiler flocks of Gallus gallus and in flocks of turkeys (Meleagris gallopavo) submitted by Poland is hereby approved for the period from 1 January 2012 to 31 December 2012.

3.The financial contribution by the Union:

(a)shall include a lump sum of EUR 0,5 per official sample taken;

(b)shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 and 2 for the cost of:

(i)

carrying out bacteriological and serotyping tests in the framework of official sampling;

(ii)

carrying out bacteriological tests to verify the efficiency of disinfection;

(iii)

carrying out tests for the detection of antimicrobials or bacterial growth inhibitory effect in tissues from birds from flocks tested for salmonella;

(iv)

the purchase of vaccine doses;

(v)

the compensation to be paid to owners for the value of:

  • the culled breeding and laying birds of Gallus gallus,

  • the culled breeding turkey birds of Meleagris gallopavo,

  • the destroyed eggs as referred to in paragraph 4; and

[F1(c) shall not exceed the following:

(i)

EUR 1 200 000 for Belgium;

(ii)

EUR 20 000 for Bulgaria;

(iii)

EUR 1 200 000 for the Czech Republic;

(iv)

EUR 250 000 for Denmark;

(v)

EUR 900 000 for Germany;

(vi)

EUR 30 000 for Estonia;

(vii)

EUR 200 000 for Ireland;

(viii)

EUR 1 000 000 for Greece;

(ix)

EUR 1 100 000 for Spain;

(x)

EUR 1 550 000 for France;

(xi)

EUR 1 200 000 for Italy;

(xii)

EUR 100 000 for Cyprus;

(xiii)

EUR 350 000 for Latvia;

(xiv)

EUR 10 000 for Luxembourg;

(xv)

EUR 2 000 000 for Hungary;

(xvi)

EUR 150 000 for Malta;

(xvii)

EUR 2 700 000 for the Netherlands;

(xviii)

EUR 1 100 000 for Austria;

(xix)

EUR 500 000 for Poland;

(xx)

EUR 50 000 for Portugal;

(xxi)

EUR 350 000 for Romania;

(xxii)

EUR 70 000 for Slovenia;

(xxiii)

EUR 600 000 for Slovakia;

(xxiv)

EUR 75 000 for the United Kingdom.]

4.The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraphs 1 and 2 shall on average not exceed:

(a)for a bacteriological test (cultivation/isolation):EUR 7 per test;
(b)for the purchase of vaccine:EUR 0,05 per dose;
(c)for serotyping of relevant isolates of salmonella spp.:EUR 20 per test;
(d)for a bacteriological test to verify the efficiency of disinfection of poultry houses after depopulation of a salmonella-positive flock:EUR 5 per test;
(e)for a test for the detection of antimicrobials or bacterial growth inhibitory effect in tissues from birds from flocks tested for salmonella:EUR 5 per test;
(f)for the compensation to be paid to owners for the value of:
(i)a parent breeding bird of Gallus gallus culled:EUR 4 per bird;
(ii)a commercial laying bird of Gallus gallus culled:EUR 2,20 per bird;
(iii)a parent breeding turkey bird of Meleagris gallopavo culled:EUR 12 per bird;
(iv)hatching eggs of parent breeding Gallus gallus:EUR 0,20 per hatching egg destroyed;
(v)table eggs of Gallus gallus:EUR 0,04 per table egg destroyed;
(vi)hatching eggs of parent breeding Meleagris gallopavo:EUR 0,40 per hatching egg destroyed.

Article 6U.K.Classical swine fever and African swine fever

1.The programmes for the control and monitoring of:

(a)Classical swine fever submitted by Bulgaria, Germany, France, Luxembourg, Hungary, Romania, Slovenia and Slovakia are hereby approved for the period from 1 January 2012 to 31 December 2012;

(b)African swine fever submitted by Italy is hereby approved for the period from 1 January 2012 to 31 December 2012.

2.[F1The financial contribution by the Union for the programmes submitted by the Member States referred to in point (a) of paragraph 1:]

(a)shall consist of a lump sum compensating for all costs incurred to perform the following activities and/or tests:

(i)

EUR 0,5 per domestic pig sampled;

(ii)

EUR 5 per wild boar sampled;

(iii)

EUR 1 per bait/vaccine;

(iv)

EUR 2 per ELISA test;

(v)

EUR 10 per PCR test;

(vi)

EUR 10 per virological test;

[F1(b) shall not exceed the following:

(i)

EUR 210 000 for Bulgaria;

(ii)

EUR 1 200 000 for Germany;

(iii)

EUR 200 000 for France;

(iv)

EUR 10 000 for Luxembourg;

(v)

EUR 340 000 for Hungary;

(vi)

EUR 900 000 for Romania;

(vii)

EUR 30 000 for Slovenia;

(viii)

EUR 500 000 for Slovakia.]

[F23. The financial contribution by the Union for the programme submitted by Italy as referred to in point (b) of paragraph 1:

(a) shall be at the rate of 50 % of the costs to be incurred by Italy for:

(i)

carrying out laboratory tests with a maximum not exceeding:

  • EUR 2 per ELISA test

  • EUR 10 per PCR test and

  • EUR 10 per virological test;

(ii)

the salaries of contractual staff specially recruited for the implementation of the measures of that programme, other than to carry out laboratory tests;

(b) shall not exceed EUR 850 000 .]

Article 7U.K.Swine vesicular disease

1.The programme for the eradication of swine vesicular disease submitted by Italy is hereby approved for the period from 1 January 2012 to 31 December 2012.

2.The financial contribution by the Union:

(a)shall consist of a lump sum compensating for all costs incurred to perform the following activities and/or tests:

(i)

EUR 0,5 per domestic pig sampled;

(ii)

EUR 2 per ELISA test;

(iii)

EUR 4 per seroneutralisation test;

(iv)

EUR 10 per PCR test;

(v)

EUR 10 per virological test;

(b)shall not exceed EUR 900 000.

Article 8U.K.Avian influenza in poultry and wild birds

1.The survey programmes for avian influenza in poultry and wild birds submitted by Belgium, Bulgaria, the Czech Republic, Denmark, Germany, Estonia, Ireland, Greece, Spain, France, Italy, Cyprus, Latvia, Lithuania, Luxembourg, Hungary, Malta, the Netherlands, Austria, Poland, Portugal, Romania, Slovenia, Slovakia, Finland, Sweden and the United Kingdom are hereby approved for the period from 1 January 2012 to 31 December 2012.

2.The financial contribution by the Union:

(a)shall consist of a lump sum compensating for all costs incurred to perform the following activities and/or tests:

(i)

EUR 0,5 per sample from poultry flocks;

(ii)

EUR 5 per wild bird sampled in the framework of the passive surveillance;

(iii)

EUR 1 per ELISA test;

(iv)

EUR 1 per agar gel immune diffusion test;

(b)shall be at the rate of 50 % of the costs to be incurred by each Member State for the costs of carrying out laboratory tests other than those foreseen in point (a); and

(c)shall not exceed the following:

(i)

EUR 40 000 for Belgium;

(ii)

EUR 40 000 for Bulgaria;

(iii)

EUR 30 000 for the Czech Republic;

(iv)

EUR 40 000 for Denmark;

(v)

EUR 80 000 for Germany;

(vi)

EUR 10 000 for Estonia;

(vii)

EUR 60 000 for Ireland;

(viii)

EUR 10 000 for Greece;

(ix)

[F1EUR 140 000 for Spain;]

(x)

EUR 130 000 for France;

(xi)

[F1EUR 1 000 000 for Italy;]

(xii)

EUR 10 000 for Cyprus;

(xiii)

EUR 20 000 for Latvia;

(xiv)

EUR 10 000 for Lithuania;

(xv)

EUR 10 000 for Luxembourg;

(xvi)

EUR 130 000 for Hungary;

(xvii)

EUR 10 000 for Malta;

(xviii)

EUR 190 000 for the Netherlands;

(xix)

EUR 50 000 for Austria;

(xx)

EUR 100 000 for Poland;

(xxi)

EUR 20 000 for Portugal;

(xxii)

[F1EUR 350 000 for Romania;]

(xxiii)

EUR 30 000 for Slovenia;

(xxiv)

EUR 20 000 for Slovakia;

(xxv)

EUR 10 000 for Finland;

(xxvi)

EUR 40 000 for Sweden;

(xxvii)

[F1EUR 110 000 for the United Kingdom.]

3.The maximum of the costs to be reimbursed to the Member States for the tests covered by the programmes shall on average not exceed:

(a)HI test for H5/H7:EUR 12 per test;
(b)virus isolation test:EUR 40 per test;
(c)PCR test:EUR 20 per test.

Article 9U.K.Transmissible spongiform encephalopathies (TSE), bovine spongiform encephalopathy (BSE) and scrapie

1.The programmes for the monitoring of transmissible spongiform encephalopathies (TSE), and for the eradication of bovine spongiform encephalopathy (BSE) and of scrapie submitted by Belgium, Bulgaria, the Czech Republic, Denmark, Germany, Estonia, Ireland, Greece, Spain, France, Italy, Cyprus, Latvia, Lithuania, Luxembourg, Hungary, Malta, the Netherlands, Austria, Poland, Portugal, Romania, Slovenia, Slovakia, Finland, Sweden, and the United Kingdom are hereby approved for the period from 1 January 2012 to 31 December 2012.

2.The financial contribution by the Union:

(a)shall consist of a lump sum of:

(i)

EUR 8,5 per test, compensating for all costs incurred to perform rapid tests, to fulfil the requirements of Article 12 paragraph 2 and Annex III Chapter A Part I to Regulation (EC) No 999/2001 or used as confirmatory tests in accordance with Annex X, Chapter C to the same Regulation;

(ii)

EUR 15 per test, compensating for all costs incurred to perform rapid tests to fulfil the requirements of Article 12 paragraph 2, Annex III Chapter A Part II points 1 to 5 and Annex VII to Regulation (EC) No 999/2001;

(iii)

EUR 4 per test, compensating for all costs incurred to perform genotyping tests;

(iv)

EUR 120 per test, compensating for all costs incurred to perform primary molecular discriminatory tests as referred to in point 3.2(c)(i) of Chapter C of Annex X to Regulation (EC) No 999/2001; and

(v)

EUR 25 per test, compensating for all costs incurred to perform confirmatory tests, other than rapid tests, as referred to in Annex X Chapter C to Regulation (EC) No 999/2001;

[F3(b) shall be at the rate of 50 % of the cost incurred by each Member State for the compensation to be paid to owners for the value of their animals:

(i)

culled and destroyed in accordance with their BSE and scrapie eradication programmes;

(ii)

compulsorily slaughtered in accordance with Annex VII, Chapter A, point 2.3(d) of Regulation (EC) No 999/2001;]

(c)shall not exceed the following:

(i)

EUR 1 220 000 for Belgium;

(ii)

[F1EUR 340 000 for Bulgaria;]

(iii)

EUR 590 000 for the Czech Republic;

(iv)

[F1EUR 750 000 for Denmark;]

(v)

[F1EUR 6 300 000 for Germany;]

(vi)

EUR 120 000 for Estonia;

(vii)

EUR 2 890 000 for Ireland;

(viii)

[F1EUR 1 800 000 for Greece;]

(ix)

EUR 4 320 000 for Spain;

(x)

EUR 12 310 000 for France;

(xi)

[F1EUR 4 800 000 for Italy;]

(xii)

EUR 1 910 000 for Cyprus;

(xiii)

EUR 220 000 for Latvia;

(xiv)

EUR 420 000 for Lithuania;

(xv)

EUR 80 000 for Luxembourg;

(xvi)

[F1EUR 1 300 000 for Hungary;]

(xvii)

EUR 20 000 for Malta;

(xviii)

[F1EUR 2 200 000 for the Netherlands;]

(xix)

EUR 1 410 000 for Austria;

(xx)

EUR 2 690 000 for Poland;

(xxi)

[F1EUR 1 100 000 for Portugal;]

(xxii)

EUR 930 000 for Romania;

(xxiii)

EUR 210 000 for Slovenia;

(xxiv)

EUR 380 000 for Slovakia;

(xxv)

EUR 350 000 for Finland;

(xxvi)

EUR 500 000 for Sweden;

(xxvii)

[F1EUR 5 100 000 for the United Kingdom.]

3.The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed:

(a)for culled and destroyed bovine animals:EUR 500 per animal;
[F3(b) for culled and destroyed sheep or goats: EUR 70 per animal;
(c) for slaughtered sheep or goats: EUR 50 per animal.]

Article 10U.K.Rabies

1.The programmes for the eradication of rabies submitted by Bulgaria, Estonia, Hungary, Poland, Romania and Slovakia are hereby approved for the period from 1 January 2012 to 31 December 2012.

2.The financial contribution by the Union:

(a)shall include a lump sum of EUR 5 per wild animal sampled;

(b)shall be at the rate of 75 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of:

(i)

carrying out laboratory tests for the detection of rabies antigen or antibodies;

(ii)

the isolation and characterisation of rabies virus;

(iii)

the detection of biomarker and the titration of vaccine baits;

(iv)

the purchase and distribution of oral vaccine plus baits;

(v)

the purchase and administration of parenteral vaccines to grazing animals; and

[F1(c) shall not exceed the following:

(i)

EUR 1 650 000 for Bulgaria;

(ii)

EUR 620 000 for Estonia;

(iii)

EUR 1 400 000 for Hungary;

(iv)

EUR 9 850 000 for Poland;

(v)

EUR 2 200 000 for Romania;

(vi)

EUR 400 000 for Slovakia.]

3.The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed:

(a)for a serological test:EUR 12 per test;
(b)for a test to detect tetracycline in bone:EUR 12 per test;
(c)for a fluorescent antibody test (FAT):EUR 18 per test;
(d)for the purchase of oral vaccine plus baits:EUR 0,60 per dose;
(e)for the distribution of oral vaccine plus baits:EUR 0,35 per dose;
(f)for the purchase of parenteral vaccine:EUR 1 per dose;
(g)for the administration of rabies vaccines to grazing animals:EUR 1,50 per animal vaccinated, regardless of the number of doses used.

4.Notwithstanding paragraph 2 points (a) and (b) and paragraph 3, for the part of the Polish programme that will be implemented outside its territory, the financial contribution by the Union shall:

(a)be granted only for the costs of the purchase and of the distribution of oral vaccine plus baits;

(b)be at the rate of 100 %; and

(c)not exceed EUR 1 260 000.

5.The maximum of the costs to be reimbursed for the costs referred to in paragraph 4 shall on average not exceed for the purchase and the distribution of oral vaccine plus baits EUR 0,95 per dose.

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Close

See additional information alongside the content

Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the EU Official Journal
  • lists of changes made by and/or affecting this legislation item
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.

The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.

For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources